Lawsuit Investigation for Patients Denied Coverage for Hepatitis C Drug Harvoni

Last Updated on October 13, 2022

Investigation Complete

Comments |

At A Glance

This Alert Affects:
People who weren’t covered by their health insurance for the cost of Harvoni, the first known drug to cure hepatitis C.
What’s Going On?
Attorneys working with are investigating whether some health insurance companies are wrongfully denying coverage for Harvoni for early-stage hepatitis C in an attempt to save money at the expense of patients’ health. It's possible that class action lawsuits could be filed to help patients get the coverage they deserve.
How Could a Class Action Help?
A successful case could order insurance companies to change the way they handle coverage for hepatitis treatment and help recover money for patients whose insurers didn’t cover their prescriptions.